A fluorescent microsphere-based method for assay of multiple analytes in plasma.

Area of Science:

• Biomedical science
• Analytical chemistry
• Biotechnology

Background:

• Traditional enzyme-linked immunosorbent assays (ELISA) are the standard for protein quantification but require individual testing per analyte, increasing sample volume demands.
• Multiplex assays offer a solution by enabling simultaneous measurement of multiple analytes within a single biological sample.
• Microsphere-based technologies are key to developing efficient multiplex assays.

Purpose of the Study:

• To present a detailed protocol for developing a multiplex assay for human plasma.
• To demonstrate the application of microsphere-based technology for simultaneous analyte detection.
• To establish a method for enhanced disease detection and management through multiplex analysis.

Main Methods:

• Utilized the BioPlex 200 platform (Bio-Rad), which is based on Luminex xMAP technology.
• Developed a protocol for preparing and running a multiplex assay specifically for human plasma samples.
• Focused on simultaneous quantification of multiple analytes.

Main Results:

• Successfully established a protocol for a multiplex assay in human plasma.
• Demonstrated the feasibility of using the BioPlex 200 platform for simultaneous analyte measurement.
• Laid the groundwork for improved diagnostic capabilities through multiplex biomarker analysis.

Conclusions:

• Multiplex assays, such as the one developed using BioPlex 200 and xMAP technology, offer a more efficient alternative to traditional single-analyte assays.
• This protocol facilitates simultaneous detection of multiple analytes in human plasma, potentially improving disease diagnosis and management.
• The developed method highlights the advantages of microsphere-based multiplexing for biomarker discovery and clinical applications.